Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-5-29
pubmed:abstractText
Recently, it has been shown that mutations in the P2 promoter of the hepatocyte nuclear factor (HNF)-4 alpha gene (HNF4A) cause maturity-onset diabetes of the young (MODY), while single nucleotide polymorphisms in this locus are associated with type 2 diabetes. In this study, we examined 1,189 bp of the P2 promoter and the associated exon 1D of HNF4A for variations associated with diabetes in 114 patients with type 2 diabetes, 72 MODYX probands, and 85 women with previous gestational diabetes mellitus. A -192c/g mutation was found in five patients. We screened 1,587 diabetic subjects and 4,812 glucose-tolerant subjects for the -192c/g mutation and identified 5 diabetic and 1 glucose-tolerant mutation carriers (P=0.004). Examination of the families showed that carriers of the -192c/g mutation had a significantly impaired glucose-stimulated insulin release and lower levels of serum total cholesterol compared with matched control subjects. Furthermore, the mutation disrupted the binding of an unidentified sequence-specific DNA binding complex present in human islet extracts. Also, two novel linked polymorphisms in the P2 promoter at positions -1107g/t and -858c/t were identified. These variants were not significantly associated with type 2 diabetes or any pre-diabetic traits. In conclusion, a rare, novel mutation that disrupts a protein binding site in the pancreatic HNF4A promoter associates with late-onset diabetes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0012-1797
pubmed:author
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1869-73
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16731855-Adult, pubmed-meshheading:16731855-Age Factors, pubmed-meshheading:16731855-Aged, pubmed-meshheading:16731855-Binding Sites, pubmed-meshheading:16731855-Blood Glucose, pubmed-meshheading:16731855-Body Mass Index, pubmed-meshheading:16731855-Diabetes Mellitus, Type 2, pubmed-meshheading:16731855-Electrophoretic Mobility Shift Assay, pubmed-meshheading:16731855-Female, pubmed-meshheading:16731855-Genotype, pubmed-meshheading:16731855-Haplotypes, pubmed-meshheading:16731855-Hepatocyte Nuclear Factor 4, pubmed-meshheading:16731855-Humans, pubmed-meshheading:16731855-Male, pubmed-meshheading:16731855-Middle Aged, pubmed-meshheading:16731855-Mutation, pubmed-meshheading:16731855-Pedigree, pubmed-meshheading:16731855-Polymorphism, Single Nucleotide, pubmed-meshheading:16731855-Promoter Regions, Genetic, pubmed-meshheading:16731855-Protein Binding, pubmed-meshheading:16731855-Sex Factors
pubmed:year
2006
pubmed:articleTitle
A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4 alpha gene (HNF4A) associates with late-onset diabetes.
pubmed:affiliation
Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Denmark.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't